Donald Allen Williams's Net Worth
$2.68 Million
Who is Donald Allen Williams?
Donald Allen Williams has an estimated net worth of $2.68 Million. This is based on reported shares across multiple companies, which include PALISADE BIO, INC., Marina Biotech, Inc., Alphatec Holdings, Inc., Forte Biosciences, Inc., and Akari Therapeutics Plc.
SEC CIK
Donald Allen Williams's CIK is 0001620013
Past Insider Trading and Trends
2023 was Donald Allen Williams's most active year for acquiring shares with 7 total transactions. Donald Allen Williams's most active month to acquire stocks was the month of May. 2018 saw Donald Allen Williams paying a total of $90,000.00 for 159,310 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PALISADE BIO, INC. (PALI) Snapshot price: $0.4598
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +50.00% | 10K |
$0.61 | $6,050.00 | 30K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 21
| |||
Form 4
|
∞
| 20K |
$0.54 | $10,800.00 | 20K |
Sep 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Marina Biotech, Inc. (ATRX) Snapshot price: $0.0164
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Alphatec Holdings, Inc. (ATEC) Snapshot price: $16.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +8.21% | 10.22K |
—
|
—
| 134.73K |
Jun 16
| |||
Form 4
| +27.63% | 26.96K |
—
|
—
| 124.51K |
Jun 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +38.95% | 18.09K |
—
|
—
| 64.52K |
Jun 21
| |||
Form 4
| +9.43% | 4K |
$2.47 | $9,890.00 | 46.43K |
Mar 12
| |||
Form 4
| +93.40% | 20.49K |
—
|
—
| 42.43K |
Jul 30
| |||
Form 4
| +630.88% | 18.94K |
—
|
—
| 21.94K |
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12
| |||
Form 4
| +16.11% | 5K |
$1.32 | $6,600.00 | 36.03K |
May 5
| |||
Form 4
|
∞
| 31.03K |
—
|
—
| 31.03K |
May 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Forte Biosciences, Inc. (FBRX) Snapshot price: $0.5551
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
∞
| 59.41K |
$1.01 | $59,999.05 | 59.41K |
Jul 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akari Therapeutics Plc (AKTX) Snapshot price: $2.94
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||